Antineutrophil cytoplasmic auto-antibodies (ANCA) in autoimmune hepatitis and primary sclerosing cholangitis

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 1, 2013, Pages 105-107

  Deniziaut, Gabrielle ^a   Ballot, Eric ^a   Johanet, Catherine ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANCA ASSOCIATED VASCULITIS; ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY TRACT DISEASE; CHRONIC LIVER DISEASE; CYTOPLASM; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; NEUTROPHIL; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STAINING; ULCERATIVE COLITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHOLANGITIS, SCLEROSING; HEPATITIS, AUTOIMMUNE; HUMANS;

EID: 84873200283     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.07.008     Document Type: Article

References (26)

1. Davies D.J., Moran J.E., Niall J.F., Ryan G.B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?. Br Med J 1982, 285:606-612.
2. Halbwachs-Mecarelli L., Nusbaum P., Noël L.H., Reumaux D., Erlinger S., Grünfeld J.P., et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992, 90:79-84.
3. Peen E., Almer S., Bodemar G., Rydén B.O., Sjölin C., Tejle K., et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 1993, 34:56-62.
4. Duerr R.H., Targan S.R., Landers C.J., LaRusso N.F., Lindsay K.L., Wiesner R.H., et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991, 100:1385-1391.
5. Seibold F., Weber P., Klein R., Berg P.A., Wiedmann K.H. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992, 33:657-662.
6. Mulder A.H., Horst G., Haagsma E.B., Limburg P.C., Kleibeuker J.H., Kallenberg C.G. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993, 17:411-417.
7. Bansi D., Chapman R., Fleming K. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass. J Hepatol 1996, 24:581-586.
8. Lindgren S., Nilsson S., Nässberger L., Verbaan H., Wieslander J. Antineutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK). J Gastroenterol Hepatol 2000, 15:437-442.
9. Targan S.R., Landers C., Vidrich A., Czaja A.J. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995, 108:1159-1166.
10. Fulcher D.A. Antineutrophil cytoplasmic antibodies in hepatobiliary disease. J Gastroenterol Hepatol 2000, 15:344-345.
11. Roozendaal C., de Jong M.A., van den Berg A.P., van Wijk R.T., Limburg P.C., Kallenberg C.G. Clinical significance of antineutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. J Hepatol 2000, 32:734-741.
12. Sobajima J., Ozaki S., Uesugi H., Osakada F., Inoue M., Fukuda Y., et al. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear antineutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 1999, 44:867-873.
13. De Riva V., Celadin M., Pittoni M., Plebani M., Angeli P. What is behind the presence of antineutrophil cytoplasmatic antibodies in chronic liver disease?. Liver Int 2009, 29:865-870.
14. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938.
15. Stoffel M.P., Csernok E., Herzberg C., Johnson T., Carroll S.F., Gross W.L. Antineutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 1996, 104:54-59.
16. Orth T., Kellner R., Diekmann O., Faust J., Meyer zum Büschenfelde K.H., Mayet W.J. Identification and characterization of auto-antibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol 1998, 112:507-515.
17. Terjung B., Herzog V., Worman H.J., Gestmann I., Bauer C., Sauerbruch T., et al. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology 1998, 28:332-340.
18. Terjung B., Spengler U., Sauerbruch T., Worman H.J. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000, 119:310-322.
19. Terjung B., Söhne J., Lechtenberg B., Gottwein J., Muennich M., Herzog V., et al. p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ. Gut 2010, 59:808-816.
20. Terjung B., Spengler U. Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut" ?. Clin Rev Allergy Immunol 2009, 36:40-51.
21. Teegen B., Niemann S., Probst C., Schlumberger W., Stöcker W., Komorowski L. DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis. Ann N Y Acad Sci 2009, 1173:161-165.
22. Zauli D., Ghetti S., Grassi A., Descovich C., Cassani F., Ballardini G., et al. Antineutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 1997, 25:1105-1107.
23. Czaja A.J., Homburger H.A. Auto-antibodies in liver disease. Gastroenterology 2001, 120:239-249.
24. Claise C., Johanet C., Bouhnik Y., Kapel N., Homberg J.C., Poupon R. Antineutroplil cytoplasmic auto-antibodies in autoimmune liver and inflammatory bowel diseases. Liver 1996, 16:28-34.
25. Bogdanos D.P., Mieli-Vergani G., Vergani D. Auto-antibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 2009, 29:241-253.
26. Terjung B., Worman H.J. Antineutrophil antibodies in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2001, 15:629-642.